lipoic acid
07/20/2017
/
By Rhonda Johansson
Lipoic acid in nutritional supplements found to help prevent multiple sclerosis, study finds
The results of a new pilot study showed the efficacy of lipoic acid in the reduction of whole brain atrophy among patients with secondary progressive multiple sclerosis (SPMS) compared with recently approved FDA drug ocrelizumab (brand name Ocrevus). In a randomized, double-blind study, researchers found that a daily dose of 1,200 mg of lipoic acid […]
« Return Home
1 of 1
Popular Articles
COPYRIGHT © 2017 SUPPLEMENTS REPORT
Privacy Policy